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Purpose

Methods

• To compare abstinence rates among
patients receiving medication- assisted
treatment (MAT) who were referred to 12step programs to those only receiving
MAT.

• Experimental Design
• Prospective cohort study

• Study Population
• English-speaking, ≥ 18 years
• DSM5 OUD diagnosis, on buprenorphine

• Low enrollment limited our ability to
determine whether combining medication
management with a 12-step program
improves abstinence.

• Primary Endpoint
• Change in positive UDS over 6 mo.
between subjects and controls

• Failure to keep appointments is common
among patients with OUD, and virtual
meetings are becoming more prevalent
post-COVID.

Results

• Developing effective enrollment strategies
is necessary to evaluate the effectiveness
of combined treatment.

Background

References

• Overdose deaths in the U.S. from opioids
have dramatically increased since the
COVID-19 pandemic
• Although MAT programs are widely
available for sufferers of opiate addiction,
many drop out of treatment prematurely

• Twelve-step programs are considered a
valuable part of treatment, but few studies
have examined the effect of combining
these approaches

Implications for Practice

Enrollment Barriers
• Excluding new patients and those attending virtual
visits
• High percentage of patients who missed
appointments
• Lack of staff referrals
• Time constraints by both staff and patients
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